Be-cause Health & QUAMED literature updates References: Faiva et al. Drug supply shortage in Nigeria during COVID‑19: efforts and challenges J of Pharm Policy and Pract (2021) 14:17 Uwizeyimana et al. Drug supply situation in Rwanda during COVID‑19: issues, efforts and challenges J of Pharm Policy and Pract (2021) 14:12 Dear Friend, Proper supply of ...
QUAMED fully supports the call to the Heads of State of the African Union to Ratify the African Medicines Agency Treaty. See for more information: https://lnkd.in/daiTKth.
Please do visit on a regular basis the IDDO site for information and to download their medical product quality reports. These reports are a great source of information. In the last issue, for example, they identified over 469 relevant articles that reported on incidents related to COVID-19 medical products. The articles covered more than 534 ...
Learning session: European citizens’ initiative for global access to Covid-19 vaccines. A Zoom session co-organised by Be-Cause health. Please see attached document to participate or follow this link: https://www.be-causehealth.be/nl/bch-events/wg-determinants-of-international-health-second-learning-session-on-access-to-covid-19-vaccines-and-technologies/
The European Public Health Alliance organises a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies. The next one is on the 8th of December. The topic is: “Will the EU be a wise ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.